Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation-Reference-Cited by-同舟云学术

Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation

Published:2023-08 Issue:8 Volume:11 Page:2392-2402
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Brás Rita^ORCID,Costa Célia^ORCID,Limão Rita^ORCID,Caldeira Leonor Esteves^ORCID,Paulino Marisa^ORCID,Pedro Elisa^ORCID

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference44 articles.

1. Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of ‘real-world’ evidence;Bernstein;Expert Opin Biol Ther,2018

2. Therapeutic strategy according to differences in response to omalizumab in patients with chronic spontaneous urticaria;Giménez Arnau;J Investig Allergol Clin Immunol,2019

3. Omalizumab updosing in chronic spontaneous urticaria: an overview of real-world evidence;Metz;Clin Rev Allergy Immunol,2020

4. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria;Maurer;N Engl J Med,2013

5. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: real-life data;Salman;Dermatol Ther,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of omalizumab updosing patterns and predictive factors in chronic spontaneous urticaria: A prospective multicentric observational study;Allergy;2024-07-26

2. Omalizumab withdrawal outcomes in chronic spontaneous urticaria are linked with baseline IgE and eosinophil levels;World Allergy Organization Journal;2024-05

3. Predicting the Speed of Response to Omalizumab in Chronic Spontaneous Urticaria;International Archives of Allergy and Immunology;2024

4. Atopy and Response to Omalizumab Treatment in Chronic Spontaneous Urticaria;International Archives of Allergy and Immunology;2023-12-19

5. Promises and Remaining Challenges for Further Integration of Basophil Activation Test in Allergy-Related Research and Clinical Practice;The Journal of Allergy and Clinical Immunology: In Practice;2023-10